Laboratorios Farmaceuticos Rovi Company Description

Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

The company offers prescription products, including Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa.

It also provides hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express; catheter care under the Fibrilin brand; and Sodium Heparin Rovi.

In addition, the company offers contract-manufacturing services comprising compounding, aseptic filling and terminal sterilisation, inspection, installation of safety devices, labelling, packaging, serialisation and aggregation, for different injectable pharmaceutical forms, such as prefilled syringes, vials and cartridges, as well as manufacturing and packaging services for solid products.

Its products are used for cardiology, osteoarticular/women’s health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.

The company was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.

Laboratorios Farmaceuticos Rovi, S.A.

Country	Spain
Founded	1946
Industry	Pharmaceutical Preparations
Employees	2,197
CEO	Juan Lopez-Belmonte Encina

Contact Details

Address: Calle JosE Isbert, 2 Madrid, 28223 Spain
Phone	34 91 021 30 00
Website	rovi.es

Stock Details

Ticker Symbol	1ROVI
Exchange	Borsa Italiana
Fiscal Year	January - December
Reporting Currency	EUR
SIC Code	2834

Key Executives

Name	Position
Juan Lopez-Belmonte Encina	Chief Executive Officer
Javier Lopez-Belmonte Encina	Chief Financial Officer
Marta Martínez	Head of Investor Relations